Literature DB >> 3838416

Computer-assisted concurrent antibiotic review in a community hospital.

P D Scarafile, B D Campbell, J E Kilroy, H O Mathewson.   

Abstract

A computer-assisted program that monitors the appropriateness of antibiotic prescribing by matching microbiology reports and patient drug profiles is described. An antibiotic review committee in conjunction with the quality assurance department developed the computer-assisted antibiotic review program. An antibiotic order sheet was incorporated into the physicians' order form. Automatic stop dates were assigned according to the reason the antibiotic was ordered, e.g., surgical prophylaxis or documented infection. Numerous reports are generated from the data gathered from the physicians' order form. A drug/microbiology report is used to match patients' antibiotic drug profiles with their microbiology culture and sensitivity results. This report identifies all patients who have been receiving antibiotics for 72 hours or longer with sensitivities on file and mismatched sensitivity results. All mismatches that are considered important are investigated. Any actions taken are reported to the antibiotic review committee for peer review. The computer-assisted program has helped this hospital screen large populations of inpatients receiving antibiotics. The concurrent review of the drug/microbiology report has made it possible to detect within 24 hours, patients who are receiving antibiotics inappropriately. A computer can be used to perform daily concurrent antibiotic use review as a by-product of order entry by both the pharmacy and laboratory.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838416

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

1.  Feasibility of an antibiotic order form. First experience in the department of internal medicine of a university hospital.

Authors:  W L Blok; I C Gyssens; Y A Hekster; P P Koopmans; J W van der Meer
Journal:  Pharm World Sci       Date:  1996-08

Review 2.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  Improved antimicrobial interventions have benefits.

Authors:  J Barenfanger; M A Short; A A Groesch
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 4.  The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspective.

Authors:  R E Polk
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.